Rafferty Asset Management
THC icon

Rafferty Asset Management’s Tenet Healthcare THC Stock Holding History

Rafferty Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
1,357
+119
+10% +$21.9K ﹤0.01% 1048
2026
Q1 		$234K Sell
1,238
-239
-16% -$50.4K ﹤0.01% 1000
2025
Q4 		$294K Sell
1,477
-49
-3% -$9.9K ﹤0.01% 1001
2025
Q3 		$310K Sell
1,526
-97
-6% -$17.2K ﹤0.01% 990
2025
Q2 		$286K Sell
1,623
-8
-0.5% -$1.2K ﹤0.01% 993
2025
Q1 		$219K Sell
1,631
-541
-25% -$71.2K ﹤0.01% 1014
2024
Q4 		$274K Sell
2,172
-38
-2% -$5.65K ﹤0.01% 1041
2024
Q3 		$367K Sell
2,210
-192
-8% -$29K ﹤0.01% 1004
2024
Q2 		$320K Buy
+2,402
New +$289K ﹤0.01% 1045
2019
Q4 		– Sell
-19,286
Closed -$427K – 903
2019
Q3 		$427K Buy
+19,286
New +$411K 0.01% 691
2019
Q2 		– Sell
-18,450
Closed -$532K – 852
2019
Q1 		$532K Buy
+18,450
New +$456K 0.01% 660

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Rafferty Asset Management's THC Position: Q2 2026 in Review

Rafferty Asset Management increased its Tenet Healthcare (THC) stake by 9.6% in Q2 2026, buying an estimated $21.9K and bringing the position to 1,357 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Rafferty Asset Management first reported a position in THC in Q1 2019 and has held it in 11 quarters since. The position peaked at $532K in Q1 2019. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Rafferty Asset Management held 1,357 shares of Tenet Healthcare worth $254K as of Q2 2026.
  • Rafferty Asset Management bought 119 Tenet Healthcare shares in Q2 2026, an estimated $21.9K.
  • Tenet Healthcare made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1048 holding.
  • Rafferty Asset Management first reported a position in Tenet Healthcare in Q1 2019 and has held it in 11 quarters since.
  • Rafferty Asset Management's Tenet Healthcare position peaked at $532K in Q1 2019.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.